Found: 66
Select item for more details and to access through your institution.
Detection of circulating tumor cells in different stages of prostate cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 5, p. 755, doi. 10.1007/s00432-013-1377-5
- By:
- Publication type:
- Article
Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Veröffentlichung von klinischen Daten für Humanarzneimittel.
- Published in:
- Pharmazeutische Industrie (Pharmind), 2015, v. 77, n. 1, p. 92
- By:
- Publication type:
- Article
Veröffentlichung von klinischen Daten für Humanarzneimittel.
- Published in:
- Pharmazeutische Industrie (Pharmind), 2014, v. 76, n. 8, p. 92
- By:
- Publication type:
- Article
Rational indication for docetaxel rechallenge in metastatic castration-resistant prostate cancer.
- Published in:
- BJU International, 2012, v. 110, n. 11b, p. E635, doi. 10.1111/j.1464-410X.2012.11364.x
- By:
- Publication type:
- Article
Androgen deprivation therapy before radical prostatectomy is associated with poorer postoperative erectile function outcomes.
- Published in:
- BJU International, 2012, v. 110, n. 1, p. 112, doi. 10.1111/j.1464-410X.2011.10728.x
- By:
- Publication type:
- Article
Molekulare Tumorboards in der Uroonkologie – Prostatakarzinom.
- Published in:
- Die Urologie, 2024, v. 63, n. 9, p. 899, doi. 10.1007/s00120-024-02399-z
- By:
- Publication type:
- Article
Matched-pair analysis of mCRPC patients receiving <sup>177</sup>Lu-labeled PSMA-targeted radioligand therapy in a 4-week versus 6-week treatment interval.
- Published in:
- EJNMMI Research, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13550-024-01143-0
- By:
- Publication type:
- Article
Intraoperative frozen section monitoring during nerve-sparing radical prostatectomy: evaluation of partial secondary resection of neurovascular bundles and its effect on oncologic and functional outcome.
- Published in:
- World Journal of Urology, 2016, v. 34, n. 2, p. 229, doi. 10.1007/s00345-015-1623-3
- By:
- Publication type:
- Article
EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 5008, doi. 10.3390/cancers15205008
- By:
- Publication type:
- Article
Prognostic Value of C-Choline PET/CT and CT for Predicting Survival of Bladder Cancer Patients Treated with Radical Cystectomy.
- Published in:
- Urologia Internationalis, 2014, v. 93, n. 2, p. 207, doi. 10.1159/000357686
- By:
- Publication type:
- Article
Automatic detection of snow avalanches in continuous seismic data using hidden Markov models.
- Published in:
- Natural Hazards & Earth System Sciences, 2018, v. 18, n. 1, p. 383, doi. 10.5194/nhess-18-383-2018
- By:
- Publication type:
- Article
Tough PEGgels by In Situ Phase Separation for 4D Printing.
- Published in:
- Advanced Functional Materials, 2024, v. 34, n. 20, p. 1, doi. 10.1002/adfm.202300947
- By:
- Publication type:
- Article
Comparison of bone scintigraphy and Ga-PSMA PET for skeletal staging in prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 12, p. 2114, doi. 10.1007/s00259-016-3435-0
- By:
- Publication type:
- Article
Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 4, p. 694, doi. 10.1007/s00259-013-2634-1
- By:
- Publication type:
- Article
Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of <sup>177</sup>Lu-PSMA I&T.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1765, doi. 10.2967/jnumed.123.265878
- By:
- Publication type:
- Article
The Impact of PSMA PET--Based Eligibility Criteria Used in the Prospective Phase II TheraP Trial in Metastatic Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen--Targeted Radioligand Therapy.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 8, p. 1252, doi. 10.2967/jnumed.122.265346
- By:
- Publication type:
- Article
<sup>177</sup>Lu-PSMA-I&T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 3, p. 402, doi. 10.2967/jnumed.122.264402
- By:
- Publication type:
- Article
<sup>177</sup>Lu-PSMA-I&T for treatment of metastatic castration resistant prostate cancer: prognostic value of scintigraphic and clinical biomarkers.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264402
- By:
- Publication type:
- Article
<sup>18</sup>F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer after Curative-intent Radiation Therapy: A Bicentric Retrospective Study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.262861
- By:
- Publication type:
- Article
<sup>177</sup>Lu-PSMA-I&T for treatment of metastatic castration resistant prostate cancer: prognostic value of scintigraphic and clinical biomarkers.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264402
- By:
- Publication type:
- Article
<sup>18</sup>F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer after Curative-intent Radiation Therapy: A Bicentric Retrospective Study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 203, doi. 10.2967/jnumed.121.262861
- By:
- Publication type:
- Article
<sup>18</sup>F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer after Curative-intent Radiation Therapy: A Bicentric Retrospective Study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 8, p. 203, doi. 10.2967/jnumed.121.262861
- By:
- Publication type:
- Article
<sup>18</sup>F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer after Curative-intent Radiation Therapy: A Bicentric Retrospective Study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.262861
- By:
- Publication type:
- Article
<sup>18</sup>F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer after Curative-intent Radiation Therapy: A Bicentric Retrospective Study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.262861
- By:
- Publication type:
- Article
<sup>18</sup>F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer after Curative-intent Radiation Therapy: A Bicentric Retrospective Study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.262861
- By:
- Publication type:
- Article
Positive predictive value and correct detection rate of <sup>18</sup>F-rhPSMA-7 PET in biochemically recurrent prostate cancer validated by composite reference standard.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.255661
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following <sup>177</sup>Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following <sup>177</sup>Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following <sup>177</sup>Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 0, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following <sup>177</sup>Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 0, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following <sup>177</sup>Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following <sup>177</sup>Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following 177Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following <sup>177</sup>Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early prostate-specific antigen changes and clinical outcome following <sup>177</sup>Lu-PSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.240242
- By:
- Publication type:
- Article
Early Experience of Rechallenge <sup>177</sup>Lu-PSMA Radioligand Therapy After an Initial Good Response in Patients with Advanced Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 5, p. 644, doi. 10.2967/jnumed.118.215715
- By:
- Publication type:
- Article
One-Stop-Shop Whole-Body <sup>68</sup>Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 12, p. 1850, doi. 10.2967/jnumed.117.207696
- By:
- Publication type:
- Article
Radiation Dosimetry for <sup>177</sup>Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 3, p. 445, doi. 10.2967/jnumed.116.178483
- By:
- Publication type:
- Article
One‐Pot Synthesis of Alternating (Ultra‐High Molecular Weight) Multiblock Copolymers via a Combination of Anionic Polymerization and Polycondensation.
- Published in:
- Macromolecular Rapid Communications, 2021, v. 42, n. 21, p. 1, doi. 10.1002/marc.202100448
- By:
- Publication type:
- Article
A 2-Gene Panel Derived From Prostate Cancer-Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Prostate, 2016, v. 76, n. 13, p. 1160, doi. 10.1002/pros.23202
- By:
- Publication type:
- Article
Automatic detection of avalanches combining array classification and localization.
- Published in:
- Earth Surface Dynamics, 2019, v. 7, n. 2, p. 491, doi. 10.5194/esurf-7-491-2019
- By:
- Publication type:
- Article
Chromogranin A and neurone-specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration-resistant prostate cancer undergoing abiraterone therapy.
- Published in:
- BJU International, 2017, v. 119, n. 1, p. 30, doi. 10.1111/bju.13493
- By:
- Publication type:
- Article
Best practices in field deployments for the seismic detection of snow avalanches.
- Published in:
- Geophysical Research Abstracts, 2019, v. 21, p. 1
- By:
- Publication type:
- Article
Automatic detection and localization of avalanches in continuous seismic data.
- Published in:
- Geophysical Research Abstracts, 2018, v. 20, p. 9196
- By:
- Publication type:
- Article
Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support.
- Published in:
- World Journal of Urology, 2023, v. 41, n. 9, p. 2343, doi. 10.1007/s00345-023-04534-5
- By:
- Publication type:
- Article
Ultrasound-based "CEUS-Bosniak"classification for cystic renal lesions: an 8-year clinical experience.
- Published in:
- World Journal of Urology, 2023, v. 41, n. 3, p. 679, doi. 10.1007/s00345-022-04094-0
- By:
- Publication type:
- Article
Hospital rating websites play a minor role for uro-oncologic patients when choosing a hospital for major surgery: results of the German multicenter NAVIGATOR-study.
- Published in:
- World Journal of Urology, 2023, v. 41, n. 2, p. 601, doi. 10.1007/s00345-022-04271-1
- By:
- Publication type:
- Article
Evaluation of Computed Tomography for Lymph Node Staging in Bladder Cancer Prior to Radical Cystectomy.
- Published in:
- Urologia Internationalis, 2016, v. 96, n. 1, p. 51, doi. 10.1159/000440889
- By:
- Publication type:
- Article